ArticleOncotarget2017
Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma.
Chao Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it